Skip to main content

Table 4 Estimated increments in each risk variable per 1 standard deviation of ln LAP or ln BMI. Population estimates derived for US adults from NHANES III (1988–1994) with adjustments for sex and race-ethnicity.

From: The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison

Dependent variable

Age (years) range

Mean outcome value, units

Observations (N) used in analyses

Increment (SE) per 1 SD in ln LAP

Increment (SE) per 1 SD in ln BMI

Total cholesterol

18–49

4.96 mmol/L

5597

0.413 (0.023)

0.225 (0.018)***

 

50+

5.75 mmol/L

3582

0.320 (0.024)

0.089 (0.022)***

HDL cholesterol

18–49

1.29 mmol/L

5571

-0.152 (0.008)

-0.111 (0.007)**

 

50+

1.32 mmol/L

3570

-0.187 (0.009)

-0.109 (0.010)***

LDL cholesterol

18–49

3.09 mmol/L

3858

0.326 (0.023)

0.220 (0.021)**

 

50+

3.62 mmol/L

2754

0.146 (0.031)

0.058 (0.026)

Total cholesterol/HDL cholest.

18–49

4.16 mmol/L

5570

0.905 (0.040)

0.584 (0.033)***

 

50+

4.74 mmol/L

3570

0.930 (0.042)

0.383 (0.042)***

Apolipo-protein B

18–49

0.97 g/L

2668†

0.123 (0.006)

0.074 (0.007)***

 

50+

1.16 g/L

1807†

0.115 (0.010)

0.056 (0.007)***

ApoB/ApoA1

18–49

0.717

2642†

0.115 (0.006)

0.074 (0.006)***

 

50+

0.810

1801†

0.109 (0.009)

0.069 (0.006)**

LDL cholesterol/ApoB

18–49

3.15 mmol/g

1813†

-0.090 (0.017)

-0.013 (0.012)**

 

50+

3.19 mmol/g

1393†

-0.160 (0.018)

-0.066 (0.022)**

Uric acid

18–49

315 μmol/L

5524

27 (1)

25 (1)

 

50+

334 μmol/L

3506

30 (2)

23 (2)*

Systolic blood pressure

18–49

115.1 mm Hg

5594

3.8 (0.2)

3.9 (0.2)

 

50+

134.1 mm Hg

3580

3.1 (0.3)

2.0 (0.4)

Diastolic blood pressure

18–49

72.9 mm Hg

5592

3.7 (0.2)

3.3 (0.2)

 

50+

75.5 mm Hg

3580

2.0 (0.2)

2.0 (0.2)

Heart rate

18–49

73.4 bpm

5482

2.4 (0.3)

1.8 (0.2)

 

50+

74.1 bpm

3493

2.2 (0.3)

1.2 (0.3)

  1. * p < 0.01, ** p < 0.001, *** p < 0.0001, indicating significantly different beta coefficients for ln LAP and ln BMI.
  2. † Lipoprotein data obtained only during phase 1 of NHANES III.